[go: up one dir, main page]

WO2002008424A1 - Human and rat abca2 genes - Google Patents

Human and rat abca2 genes Download PDF

Info

Publication number
WO2002008424A1
WO2002008424A1 PCT/JP2001/006457 JP0106457W WO0208424A1 WO 2002008424 A1 WO2002008424 A1 WO 2002008424A1 JP 0106457 W JP0106457 W JP 0106457W WO 0208424 A1 WO0208424 A1 WO 0208424A1
Authority
WO
WIPO (PCT)
Prior art keywords
base sequence
abca2
rat
genes
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2001/006457
Other languages
French (fr)
Japanese (ja)
Inventor
Nobuya Inagaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Priority to AU2001276686A priority Critical patent/AU2001276686A1/en
Publication of WO2002008424A1 publication Critical patent/WO2002008424A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A polynucleotide having a base sequence encoding a protein having an amino acid sequence represented by SEQ ID NO:2 or 5; a polynucleotide having a base sequence derived therefrom by substitution, addition or deletion of one or more bases; and a method of diagnosing a diseases in which ABCA2 gene participates which comprises comparing the base sequence of the above polynucleotide with the base sequence of ABCA2 gene in a biological sample obtained from a subject.
PCT/JP2001/006457 2000-07-26 2001-07-26 Human and rat abca2 genes Ceased WO2002008424A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001276686A AU2001276686A1 (en) 2000-07-26 2001-07-26 Human and rat abca2 genes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000225462A JP2004147502A (en) 2000-07-26 2000-07-26 Human and rat ABCA2 genes
JP2000-225462 2000-07-26

Publications (1)

Publication Number Publication Date
WO2002008424A1 true WO2002008424A1 (en) 2002-01-31

Family

ID=18719229

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/006457 Ceased WO2002008424A1 (en) 2000-07-26 2001-07-26 Human and rat abca2 genes

Country Status (3)

Country Link
JP (1) JP2004147502A (en)
AU (1) AU2001276686A1 (en)
WO (1) WO2002008424A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1214415A4 (en) * 1999-09-20 2003-09-17 Fox Chase Cancer Ct FOR THE HUMAN ABCA TRANSPORTER 2 (ABCA2) ENCODING NUCLEIC ACID AND METHOD FOR THEIR APPLICATION
FR2856409A1 (en) * 2003-06-20 2004-12-24 Aventis Pharma Sa METHODS OF DETECTING ALZHEIMER'S DISEASE
US7803538B2 (en) 2003-06-20 2010-09-28 Aventis Pharma Sa Method for detecting Alzheimer's disease
CN102768189A (en) * 2012-07-30 2012-11-07 黄石 Method for screening drugs

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037764A1 (en) * 1997-02-27 1998-09-03 Baylor College Of Medicine Nucleic acid sequences for atp-binding cassette transporter
WO2001021798A2 (en) * 1999-09-20 2001-03-29 Fox Chase Cancer Center Nucleic acid encoding human abca transporter 2 (abca2) and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037764A1 (en) * 1997-02-27 1998-09-03 Baylor College Of Medicine Nucleic acid sequences for atp-binding cassette transporter
WO2001021798A2 (en) * 1999-09-20 2001-03-29 Fox Chase Cancer Center Nucleic acid encoding human abca transporter 2 (abca2) and methods of use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARIE FRANCOISE LUCIANI ET AL.: "Cloning of two novel ABC trans porters mapping on human chromosome 9", GENOMICS, vol. 21, no. 1, 1994, pages 150 - 159, XP002945942 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1214415A4 (en) * 1999-09-20 2003-09-17 Fox Chase Cancer Ct FOR THE HUMAN ABCA TRANSPORTER 2 (ABCA2) ENCODING NUCLEIC ACID AND METHOD FOR THEIR APPLICATION
FR2856409A1 (en) * 2003-06-20 2004-12-24 Aventis Pharma Sa METHODS OF DETECTING ALZHEIMER'S DISEASE
WO2004113568A3 (en) * 2003-06-20 2005-05-06 Aventis Pharma Sa Methods for the diagnosis and prognosis of alzheimer's disease
US7803538B2 (en) 2003-06-20 2010-09-28 Aventis Pharma Sa Method for detecting Alzheimer's disease
CN102768189A (en) * 2012-07-30 2012-11-07 黄石 Method for screening drugs

Also Published As

Publication number Publication date
AU2001276686A1 (en) 2002-02-05
JP2004147502A (en) 2004-05-27

Similar Documents

Publication Publication Date Title
WO2001079463A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
WO2001079462A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
EP2189475A3 (en) Fibroblast growth factor-like polypeptides
WO2003020932A1 (en) Novel secretory proteins and dna thereof
WO1999057311A3 (en) Novel method for the identification of clones conferring a desired biological property from an expression library
WO2000027994A3 (en) Chlamydia pneumoniae genome sequence
WO2000001823A3 (en) Flt3-l mutants and methods of use
WO2001068854A3 (en) Fibroblast growth factor-like molecules and uses thereof
DK0966533T3 (en) Activity-dependent neurotrophic factor III (ADNF III).
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
WO2002008424A1 (en) Human and rat abca2 genes
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
EP1757684A3 (en) A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme
WO2003054158A3 (en) Rapidly maturing fluorescent proteins and methods for using the same
WO2001092495A3 (en) A human lysyl ixodase (47765) and uses thereof
CA2413670A1 (en) Human brain and testis-specific immunoglobulin superfamily (bt-igsf) cdna for diagnosis of aplasia of corpus callosum and aspermatogenesis
WO2003018806A1 (en) Novel human bmcc1 gene
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof
EP0911408A3 (en) DNA coding for serine/threonine kinase
WO2001081546A3 (en) CeSERT GENES, PROTEINS, AND MODULATORY COMPOUNDS
EP1757693A3 (en) Nucleic acids showing difference in expression between hepatoblastoma and normal liver
WO2002000829A3 (en) A novel peptide--- human ftsh protein 16.83 and the polynucleotide coding this novel peptide
WO2005086595A3 (en) Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
WO2002077009A3 (en) Polypeptides having gamma-glutamyl transpeptidase activity and nucleic acids encoding same
WO2002026978A1 (en) Novel proteins, genes encoding them and method of using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP